Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

TD Cowen Reaffirms Their Buy Rating on Metlife (MET)

Tipranks - Tipranks - Thu Mar 12, 6:42AM CDT

TD Cowen analyst Andrew Kligerman maintained a Buy rating on Metlife today and set a price target of $88.00.

Claim 70% Off TipRanks Premium

According to TipRanks, Kligerman is a 4-star analyst with an average return of 8.9% and a 60.89% success rate. Kligerman covers the Financial sector, focusing on stocks such as AFLAC, Metlife, and Prudential Financial.

In addition to TD Cowen, Metlife also received a Buy from TipRanks – PerPlexity’s PerPlexity Insurance – Life in a report issued on March 6. However, on the same day, TipRanks – xAI reiterated a Hold rating on Metlife (NYSE: MET).

See Insiders’ Hot Stocks on TipRanks >>

Based on Metlife’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $23.81 billion and a net profit of $809 million. In comparison, last year the company earned a revenue of $18.44 billion and had a net profit of $1.27 billion

Read More on MET:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).